▶ 調査レポート

世界のセルトリズマブペゴル市場予測(~2024年)

• 英文タイトル:Global Certolizumab pegol Market 2019 by Company, Regions, Type and Application, Forecast to 2024

GlobalInfoResearchが調査・発行した産業分析レポートです。世界のセルトリズマブペゴル市場予測(~2024年) / Global Certolizumab pegol Market 2019 by Company, Regions, Type and Application, Forecast to 2024 / B-GIR09D3841資料のイメージです。• レポートコード:B-GIR09D3841
• 出版社/出版日:GlobalInfoResearch / 2019年9月18日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、102ページ
• 納品方法:Eメール
• 産業分類:医薬品・ヘルスケア
• 販売価格(消費税別)
  Single User¥515,040 (USD3,480)▷ お問い合わせ
  Multi User¥772,560 (USD5,220)▷ お問い合わせ
  Corporate User¥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートは、セルトリズマブペゴルの世界市場について調べ、まとめました。種類別セグメントは、単回投与バイアル、単回投与プレフィルドシリンジ等、用途別セグメントは、クローン病、活動性関節リウマチ、活動性乾癬性関節炎等に区分しました。セルトリズマブペゴルの世界市場概観、企業動向、企業別セルトリズマブペゴルシェア、市場規模推移、市場規模予測(2019年-2024年)、主要地域分析(北米、ヨーロッパ、アジア等)、主要国分析(日本、中国、アメリカ等)データなどの情報が含まれています。
・セルトリズマブペゴルの市場概観
・セルトリズマブペゴルの企業概要(事業概要、製品種類、販売量、価格、売上、市場シェア等)
・セルトリズマブペゴルの企業別販売動向、市場シェア、市場集中度、競争動向
・セルトリズマブペゴルの世界市場規模
・セルトリズマブペゴルの北米市場分析(アメリカ、カナダ、メキシコ等)
・セルトリズマブペゴルのアメリカ市場規模推移
・セルトリズマブペゴルのカナダ市場規模推移
・セルトリズマブペゴルのメキシコ市場規模推移
・セルトリズマブペゴルのヨーロッパ市場分析(ドイツ、イギリス、ロシア、フランス、イタリア等)
・セルトリズマブペゴルのドイツ市場規模推移
・セルトリズマブペゴルのイギリス市場規模推移
・セルトリズマブペゴルのロシア市場規模推移
・セルトリズマブペゴルのアジア太平洋市場分析(日本、中国、韓国、インド、東南アジア等)
・セルトリズマブペゴルの日本市場規模推移
・セルトリズマブペゴルの中国市場規模推移
・セルトリズマブペゴルの韓国市場規模推移
・セルトリズマブペゴルのインド市場規模推移
・セルトリズマブペゴルの東南アジア市場規模推移
・セルトリズマブペゴルの南米市場分析(ブラジル、アルゼンチン等)
・セルトリズマブペゴルの中東・アフリカ市場分析(サウジアラビア、UAE、南アフリカ等)
・セルトリズマブペゴルの種類別分析/販売量、売上、市場シェア(単回投与バイアル、単回投与プレフィルドシリンジ)
・セルトリズマブペゴルの用途別分析/市場規模(クローン病、活動性関節リウマチ、活動性乾癬性関節炎)
・セルトリズマブペゴルの市場予測2019年-2024年(地域別予測、種類別予測、用途別予測)
・セルトリズマブペゴルの販売チャネル・代理店・貿易業者・ディーラー分析

Certolizumab pegol (CDP870, tradename Cimzia) is a biologic medication for the treatment of Crohn’s disease, rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis.

Scope of the Report:
The global Certolizumab pegol market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Certolizumab pegol.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Certolizumab pegol market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Certolizumab pegol market by product type and applications/end industries.

Market Segment by Companies, this report covers
UCB

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Single-dose vial
Single-dose prefilled syringe

Market Segment by Applications, can be divided into
Crohn’s disease
Active rheumatoid arthritis
Active psoriatic arthritis

レポート目次

Table of Contents

1 Certolizumab pegol Market Overview
1.1 Product Overview and Scope of Certolizumab pegol
1.2 Classification of Certolizumab pegol by Types
1.2.1 Global Certolizumab pegol Revenue Comparison by Types (2019-2024)
1.2.2 Global Certolizumab pegol Revenue Market Share by Types in 2018
1.2.3 Single-dose vial
1.2.4 Single-dose prefilled syringe
1.3 Global Certolizumab pegol Market by Application
1.3.1 Global Certolizumab pegol Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Crohn’s disease
1.3.3 Active rheumatoid arthritis
1.3.4 Active psoriatic arthritis
1.4 Global Certolizumab pegol Market by Regions
1.4.1 Global Certolizumab pegol Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Certolizumab pegol Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Certolizumab pegol Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Certolizumab pegol Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Certolizumab pegol Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Certolizumab pegol Status and Prospect (2014-2024)
1.5 Global Market Size of Certolizumab pegol (2014-2024)
2 Manufacturers Profiles
2.1 UCB
2.1.1 Business Overview
2.1.2 Certolizumab pegol Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 UCB Certolizumab pegol Revenue, Gross Margin and Market Share (2017-2018)
3 Global Certolizumab pegol Market Competition, by Players
3.1 Global Certolizumab pegol Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Certolizumab pegol Players Market Share
3.2.2 Top 10 Certolizumab pegol Players Market Share
3.3 Market Competition Trend
4 Global Certolizumab pegol Market Size by Regions
4.1 Global Certolizumab pegol Revenue and Market Share by Regions
4.2 North America Certolizumab pegol Revenue and Growth Rate (2014-2019)
4.3 Europe Certolizumab pegol Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Certolizumab pegol Revenue and Growth Rate (2014-2019)
4.5 South America Certolizumab pegol Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Certolizumab pegol Revenue and Growth Rate (2014-2019)
5 North America Certolizumab pegol Revenue by Countries
5.1 North America Certolizumab pegol Revenue by Countries (2014-2019)
5.2 USA Certolizumab pegol Revenue and Growth Rate (2014-2019)
5.3 Canada Certolizumab pegol Revenue and Growth Rate (2014-2019)
5.4 Mexico Certolizumab pegol Revenue and Growth Rate (2014-2019)
6 Europe Certolizumab pegol Revenue by Countries
6.1 Europe Certolizumab pegol Revenue by Countries (2014-2019)
6.2 Germany Certolizumab pegol Revenue and Growth Rate (2014-2019)
6.3 UK Certolizumab pegol Revenue and Growth Rate (2014-2019)
6.4 France Certolizumab pegol Revenue and Growth Rate (2014-2019)
6.5 Russia Certolizumab pegol Revenue and Growth Rate (2014-2019)
6.6 Italy Certolizumab pegol Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Certolizumab pegol Revenue by Countries
7.1 Asia-Pacific Certolizumab pegol Revenue by Countries (2014-2019)
7.2 China Certolizumab pegol Revenue and Growth Rate (2014-2019)
7.3 Japan Certolizumab pegol Revenue and Growth Rate (2014-2019)
7.4 Korea Certolizumab pegol Revenue and Growth Rate (2014-2019)
7.5 India Certolizumab pegol Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Certolizumab pegol Revenue and Growth Rate (2014-2019)
8 South America Certolizumab pegol Revenue by Countries
8.1 South America Certolizumab pegol Revenue by Countries (2014-2019)
8.2 Brazil Certolizumab pegol Revenue and Growth Rate (2014-2019)
8.3 Argentina Certolizumab pegol Revenue and Growth Rate (2014-2019)
8.4 Colombia Certolizumab pegol Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Certolizumab pegol by Countries
9.1 Middle East and Africa Certolizumab pegol Revenue by Countries (2014-2019)
9.2 Saudi Arabia Certolizumab pegol Revenue and Growth Rate (2014-2019)
9.3 UAE Certolizumab pegol Revenue and Growth Rate (2014-2019)
9.4 Egypt Certolizumab pegol Revenue and Growth Rate (2014-2019)
9.5 Nigeria Certolizumab pegol Revenue and Growth Rate (2014-2019)
9.6 South Africa Certolizumab pegol Revenue and Growth Rate (2014-2019)
10 Global Certolizumab pegol Market Segment by Type
10.1 Global Certolizumab pegol Revenue and Market Share by Type (2014-2019)
10.2 Global Certolizumab pegol Market Forecast by Type (2019-2024)
10.3 Single-dose vial Revenue Growth Rate (2014-2024)
10.4 Single-dose prefilled syringe Revenue Growth Rate (2014-2024)
11 Global Certolizumab pegol Market Segment by Application
11.1 Global Certolizumab pegol Revenue Market Share by Application (2014-2019)
11.2 Certolizumab pegol Market Forecast by Application (2019-2024)
11.3 Crohn’s disease Revenue Growth (2014-2019)
11.4 Active rheumatoid arthritis Revenue Growth (2014-2019)
11.5 Active psoriatic arthritis Revenue Growth (2014-2019)
12 Global Certolizumab pegol Market Size Forecast (2019-2024)
12.1 Global Certolizumab pegol Market Size Forecast (2019-2024)
12.2 Global Certolizumab pegol Market Forecast by Regions (2019-2024)
12.3 North America Certolizumab pegol Revenue Market Forecast (2019-2024)
12.4 Europe Certolizumab pegol Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Certolizumab pegol Revenue Market Forecast (2019-2024)
12.6 South America Certolizumab pegol Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Certolizumab pegol Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure Certolizumab pegol Picture
Table Product Specifications of Certolizumab pegol
Table Global Certolizumab pegol and Revenue (Million USD) Market Split by Product Type
Figure Global Certolizumab pegol Revenue Market Share by Types in 2018
Figure Single-dose vial Picture
Figure Single-dose prefilled syringe Picture
Table Global Certolizumab pegol Revenue (Million USD) by Application (2014-2024)
Figure Certolizumab pegol Revenue Market Share by Applications in 2018
Figure Crohn’s disease Picture
Figure Active rheumatoid arthritis Picture
Figure Active psoriatic arthritis Picture
Table Global Market Certolizumab pegol Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Certolizumab pegol Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Certolizumab pegol Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Certolizumab pegol Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Certolizumab pegol Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Certolizumab pegol Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Certolizumab pegol Revenue (Million USD) and Growth Rate (2014-2024)
Table UCB Basic Information, Manufacturing Base and Competitors
Table UCB Certolizumab pegol Type and Applications
Table UCB Certolizumab pegol Revenue, Gross Margin and Market Share (2017-2018)
Table Global Certolizumab pegol Revenue (Million USD) by Players (2014-2019)
Table Global Certolizumab pegol Revenue Share by Players (2014-2019)
Figure Global Certolizumab pegol Revenue Share by Players in 2017
Figure Global Certolizumab pegol Revenue Share by Players in 2018
Figure Global Top 5 Players Certolizumab pegol Revenue Market Share in 2018
Figure Global Top 10 Players Certolizumab pegol Revenue Market Share in 2018
Figure Global Certolizumab pegol Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Certolizumab pegol Revenue (Million USD) by Regions (2014-2019)
Table Global Certolizumab pegol Revenue Market Share by Regions (2014-2019)
Figure Global Certolizumab pegol Revenue Market Share by Regions (2014-2019)
Figure Global Certolizumab pegol Revenue Market Share by Regions in 2018
Figure North America Certolizumab pegol Revenue and Growth Rate (2014-2019)
Figure Europe Certolizumab pegol Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Certolizumab pegol Revenue and Growth Rate (2014-2019)
Figure South America Certolizumab pegol Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Certolizumab pegol Revenue and Growth Rate (2014-2019)
Table North America Certolizumab pegol Revenue by Countries (2014-2019)
Table North America Certolizumab pegol Revenue Market Share by Countries (2014-2019)
Figure North America Certolizumab pegol Revenue Market Share by Countries (2014-2019)
Figure North America Certolizumab pegol Revenue Market Share by Countries in 2018
Figure USA Certolizumab pegol Revenue and Growth Rate (2014-2019)
Figure Canada Certolizumab pegol Revenue and Growth Rate (2014-2019)
Figure Mexico Certolizumab pegol Revenue and Growth Rate (2014-2019)
Table Europe Certolizumab pegol Revenue (Million USD) by Countries (2014-2019)
Figure Europe Certolizumab pegol Revenue Market Share by Countries (2014-2019)
Figure Europe Certolizumab pegol Revenue Market Share by Countries in 2018
Figure Germany Certolizumab pegol Revenue and Growth Rate (2014-2019)
Figure UK Certolizumab pegol Revenue and Growth Rate (2014-2019)
Figure France Certolizumab pegol Revenue and Growth Rate (2014-2019)
Figure Russia Certolizumab pegol Revenue and Growth Rate (2014-2019)
Figure Italy Certolizumab pegol Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Certolizumab pegol Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Certolizumab pegol Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Certolizumab pegol Revenue Market Share by Countries in 2018
Figure China Certolizumab pegol Revenue and Growth Rate (2014-2019)
Figure Japan Certolizumab pegol Revenue and Growth Rate (2014-2019)
Figure Korea Certolizumab pegol Revenue and Growth Rate (2014-2019)
Figure India Certolizumab pegol Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Certolizumab pegol Revenue and Growth Rate (2014-2019)
Table South America Certolizumab pegol Revenue by Countries (2014-2019)
Table South America Certolizumab pegol Revenue Market Share by Countries (2014-2019)
Figure South America Certolizumab pegol Revenue Market Share by Countries (2014-2019)
Figure South America Certolizumab pegol Revenue Market Share by Countries in 2018
Figure Brazil Certolizumab pegol Revenue and Growth Rate (2014-2019)
Figure Argentina Certolizumab pegol Revenue and Growth Rate (2014-2019)
Figure Colombia Certolizumab pegol Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Certolizumab pegol Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Certolizumab pegol Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Certolizumab pegol Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Certolizumab pegol Revenue Market Share by Countries in 2018
Figure Saudi Arabia Certolizumab pegol Revenue and Growth Rate (2014-2019)
Figure UAE Certolizumab pegol Revenue and Growth Rate (2014-2019)
Figure Egypt Certolizumab pegol Revenue and Growth Rate (2014-2019)
Figure Nigeria Certolizumab pegol Revenue and Growth Rate (2014-2019)
Figure South Africa Certolizumab pegol Revenue and Growth Rate (2014-2019)
Table Global Certolizumab pegol Revenue (Million USD) by Type (2014-2019)
Table Global Certolizumab pegol Revenue Share by Type (2014-2019)
Figure Global Certolizumab pegol Revenue Share by Type (2014-2019)
Figure Global Certolizumab pegol Revenue Share by Type in 2019
Table Global Certolizumab pegol Revenue Forecast by Type (2019-2024)
Figure Global Certolizumab pegol Market Share Forecast by Type (2019-2024)
Figure Global Single-dose vial Revenue Growth Rate (2014-2019)
Figure Global Single-dose prefilled syringe Revenue Growth Rate (2014-2019)
Table Global Certolizumab pegol Revenue by Application (2014-2019)
Table Global Certolizumab pegol Revenue Share by Application (2014-2019)
Figure Global Certolizumab pegol Revenue Share by Application (2014-2019)
Figure Global Certolizumab pegol Revenue Share by Application in 2019
Table Global Certolizumab pegol Revenue Forecast by Application (2019-2024)
Figure Global Certolizumab pegol Market Share Forecast by Application (2019-2024)
Figure Global Crohn’s disease Revenue Growth Rate (2014-2019)
Figure Global Active rheumatoid arthritis Revenue Growth Rate (2014-2019)
Figure Global Active psoriatic arthritis Revenue Growth Rate (2014-2019)
Figure Global Certolizumab pegol Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Certolizumab pegol Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Certolizumab pegol Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Certolizumab pegol Revenue Market Forecast (2019-2024)
Figure Europe Certolizumab pegol Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Certolizumab pegol Revenue Market Forecast (2019-2024)
Figure South America Certolizumab pegol Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Certolizumab pegol Revenue Market Forecast (2019-2024)